Cargando…
HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure
BACKGROUND: Some patients with idiopathic pulmonary fibrosis (IPF) must be hospitalized because of heart failure (HF), including HF with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF). The association between IPF and HF has not been clarified. We retrospectively investigated the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822325/ https://www.ncbi.nlm.nih.gov/pubmed/33481923 http://dx.doi.org/10.1371/journal.pone.0245778 |
_version_ | 1783639608764923904 |
---|---|
author | Yamazaki, Ryo Nishiyama, Osamu Yoshikawa, Kazuya Saeki, Sho Sano, Hiroyuki Iwanaga, Takashi Tohda, Yuji |
author_facet | Yamazaki, Ryo Nishiyama, Osamu Yoshikawa, Kazuya Saeki, Sho Sano, Hiroyuki Iwanaga, Takashi Tohda, Yuji |
author_sort | Yamazaki, Ryo |
collection | PubMed |
description | BACKGROUND: Some patients with idiopathic pulmonary fibrosis (IPF) must be hospitalized because of heart failure (HF), including HF with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF). The association between IPF and HF has not been clarified. We retrospectively investigated the clinical features and outcomes of patients with IPF who required nonelective hospitalization because of HF. METHODS: We examined data from IPF patients who required nonelective hospitalization for HF at the Kindai University Hospital from January 2008 to December 2018. We divided the patients into 3 groups: those with HFpEF without elevated right ventricular systolic pressure (RVSP), those with HFpEF and elevated RVSP, and those with HFrEF. The recurrence rates of HF after discharge and the 30- and 90-day mortality rates of the patients were evaluated. RESULTS: During the study period, 37 patients with IPF required hospitalization because of HF. Among the 34 patients included in the study, 17 (50.0%) were diagnosed with HFpEF without elevated RVSP, 11 (32.3%) with HFpEF and elevated RVSP, and 6 (17.6%) with HFrEF. Patients with HFrEF had significantly higher values for B-type natriuretic peptide (BNP) and left ventricular (LV) end-systolic and end-diastolic diameters than patients with the 2 types of HFpEF (BNP: P = 0.01 and P = 0.0004, LV end-systolic diameter: P <0.0001 and P <0.0001, and LV end-diastolic diameter: P = 0.01 and P = 0.0004, respectively). Notably, the difference between the LVEFs of the patients with 2 types of HFpEF was not significant. The patients with HFpEF without elevated RVSP had the lowest 30- and 90-day mortality rates (0%, P = 0.02 and 11.7%, P = 0.11, respectively). CONCLUSIONS: Among patients with IPF, HFpEF without elevated RVSP was the most common type of HF that required hospitalization. Patients with HFpEF without elevated RVSP survived longer than the patients with the other 2 types of HF. |
format | Online Article Text |
id | pubmed-7822325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-78223252021-01-29 HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure Yamazaki, Ryo Nishiyama, Osamu Yoshikawa, Kazuya Saeki, Sho Sano, Hiroyuki Iwanaga, Takashi Tohda, Yuji PLoS One Research Article BACKGROUND: Some patients with idiopathic pulmonary fibrosis (IPF) must be hospitalized because of heart failure (HF), including HF with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF). The association between IPF and HF has not been clarified. We retrospectively investigated the clinical features and outcomes of patients with IPF who required nonelective hospitalization because of HF. METHODS: We examined data from IPF patients who required nonelective hospitalization for HF at the Kindai University Hospital from January 2008 to December 2018. We divided the patients into 3 groups: those with HFpEF without elevated right ventricular systolic pressure (RVSP), those with HFpEF and elevated RVSP, and those with HFrEF. The recurrence rates of HF after discharge and the 30- and 90-day mortality rates of the patients were evaluated. RESULTS: During the study period, 37 patients with IPF required hospitalization because of HF. Among the 34 patients included in the study, 17 (50.0%) were diagnosed with HFpEF without elevated RVSP, 11 (32.3%) with HFpEF and elevated RVSP, and 6 (17.6%) with HFrEF. Patients with HFrEF had significantly higher values for B-type natriuretic peptide (BNP) and left ventricular (LV) end-systolic and end-diastolic diameters than patients with the 2 types of HFpEF (BNP: P = 0.01 and P = 0.0004, LV end-systolic diameter: P <0.0001 and P <0.0001, and LV end-diastolic diameter: P = 0.01 and P = 0.0004, respectively). Notably, the difference between the LVEFs of the patients with 2 types of HFpEF was not significant. The patients with HFpEF without elevated RVSP had the lowest 30- and 90-day mortality rates (0%, P = 0.02 and 11.7%, P = 0.11, respectively). CONCLUSIONS: Among patients with IPF, HFpEF without elevated RVSP was the most common type of HF that required hospitalization. Patients with HFpEF without elevated RVSP survived longer than the patients with the other 2 types of HF. Public Library of Science 2021-01-22 /pmc/articles/PMC7822325/ /pubmed/33481923 http://dx.doi.org/10.1371/journal.pone.0245778 Text en © 2021 Yamazaki et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Yamazaki, Ryo Nishiyama, Osamu Yoshikawa, Kazuya Saeki, Sho Sano, Hiroyuki Iwanaga, Takashi Tohda, Yuji HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure |
title | HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure |
title_full | HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure |
title_fullStr | HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure |
title_full_unstemmed | HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure |
title_short | HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure |
title_sort | hfpef without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with ipf requiring hospitalization for heart failure |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822325/ https://www.ncbi.nlm.nih.gov/pubmed/33481923 http://dx.doi.org/10.1371/journal.pone.0245778 |
work_keys_str_mv | AT yamazakiryo hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure AT nishiyamaosamu hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure AT yoshikawakazuya hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure AT saekisho hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure AT sanohiroyuki hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure AT iwanagatakashi hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure AT tohdayuji hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure |